Ankit Watts

Chandigarh, CH 160012, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging.

A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging.

Journal: Nuclear medicine communications
Published: March 07, 2026

99mTc-HYNIC-PSMA-11 Whole-Body SPECT/CT: A Clinically Viable Alternative to 68Ga-PSMA PET/CT in patients with Prostate Cancer.

99mTc-HYNIC-PSMA-11 Whole-Body SPECT/CT: A Clinically Viable Alternative to 68Ga-PSMA PET/CT in patients with Prostate Cancer.

Journal: The British journal of radiology
Published: April 19, 2025

99mTc-HYNIC-PSMA-11 whole-body SPECT/CT: a clinically viable alternative to 68Ga-PSMA PET/CT in patients with prostate cancer.

99mTc-HYNIC-PSMA-11 whole-body SPECT/CT: a clinically viable alternative to 68Ga-PSMA PET/CT in patients with prostate cancer.

Journal: The British journal of radiology
Published: April 19, 2025

Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways.

Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways.

Journal: Archives of medical research
Published: April 04, 2025

Detection of Extramedullary Laryngeal Involvement on 68 Ga-Pentixafor PET/CT in a Newly Diagnosed Patient of Multiple Myeloma.

Detection of Extramedullary Laryngeal Involvement on 68 Ga-Pentixafor PET/CT in a Newly Diagnosed Patient of Multiple Myeloma.

Journal: Clinical nuclear medicine
Published: November 22, 2024

68 Ga-Pentixafor PET/CT-Based Response Evaluation and its Prognostic Value in Multiple Myeloma: Comparison With IMWG and 18 F-FDG-Based Response.

68 Ga-Pentixafor PET/CT-Based Response Evaluation and its Prognostic Value in Multiple Myeloma: Comparison With IMWG and 18 F-FDG-Based Response.

Journal: Clinical nuclear medicine
Published: November 07, 2024

Current Status and Future Perspectives of CXCR4-based Radio-theranostics in Human Cancers: A Review.

Current Status and Future Perspectives of CXCR4-based Radio-theranostics in Human Cancers: A Review.

Journal: Clinical nuclear medicine
Published: September 14, 2024

68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.

68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.

Journal: Clinical nuclear medicine
Published: February 13, 2024

68 Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.

68 Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.

Journal: Nuclear medicine communications
Published: January 02, 2024

India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate.

India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate.

Journal: Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
Published: July 11, 2023

Radiotheranostics Practice in India- Advancing to Precision Oncology.

Radiotheranostics Practice in India- Advancing to Precision Oncology.

Journal: Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
Published: February 27, 2023

Comparison of Internal Dosimetry of 18 F-PSMA-1007 and 68 Ga-PSMA-11-HBED-CC.

Comparison of Internal Dosimetry of 18 F-PSMA-1007 and 68 Ga-PSMA-11-HBED-CC.

Journal: Clinical nuclear medicine
Published: August 12, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026